Wednesday, March 03, 2021 10:21:20 AM
2020 (YES...2020) Objectives: “Completion of [IsoTherapeutic’s] Isolated Production Center”
Over a year off.
IF they complete IsoTherapeutic’s (most of the time they do not mention who will truly who own it) Isolated Production Center March 2021. Again, most plans have been scrapped or mothballed mostly for good reasons like lack of monies. If even if they complete it will “set the stage” for another stage setter probably haha! I joke kind of but it is truly necessary. It is a foundational piece. It would be even better if it were completely owned by Vivos. Maybe that will happen in the future?
Still no clarity on the pre-submission meeting. Pre-submission meeting for IDE was supposed to happen in November 2021 with a submission in April 2021. Did the BDD process check the box for the presubmission meeting which puts the submission at August? If not when do they anticipate the pre-submission to occur?
Also, I agree with a couple of folks on this board that they should avoid detours like STEP and just simply focus on IDE. Just entertaining the idea is frustrating.
POSSIBLE IDE approval (ONE of TWO catalysts that would really move the needle on this stock) August 2021 - February 2022.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM